The latest research & treatment news about Hepatitis C infection, diagnosis, symptoms and treatment.

Home
News
Information
Treatment
- Hepatitis C Medicines
- Liver Support/Meds
Liver Supplements
Support
Diet
Free Newsletter

Hepatitis C Treatments/Therapies

Harvoni – A Complete Guide

Dec 17, 2018

Have questions about Harvoni? We've got answers. Discover all there is to know about this potent Hepatitis C treatment, including when a less costly, generic version is due out in 2019.

Is the High Cost of New Hep C Drugs Worth the Money?

Dec 13, 2018 21 Comments

A recently released study takes on the question, “Does the value of the new Hepatitis C drugs legitimize their price?”

Curing Hepatitis C Improves Extrahepatic Manifestations

Jun 11, 2018

Getting the latest treatment to eradicate the Hepatitis C virus has benefits that go well beyond liver health.

New HCV Combination Treatment for Only $300 in Lower-Income Countries

Apr 13, 2018

Learn more about ravidasvir/sofosbuvir treatment, a new 12-week course of daily Hepatitis C treatment that was demonstrated in clinical trials to completely stamp out traces of HCV from 97 percent of the study’s patients.

Hepatitis C Drug News for 2018 – No Pipeline

Jan 3, 2018 5 Comments

High success rates of the newer Hepatitis C drugs change the economics of drug development for this virus.

How Do Older Folks Fare on the New Hep C Meds?

Oct 3, 2017 9 Comments

Especially because of the current recommendations to screen patients born between 1945 and 1965 for Hepatitis C, understanding the efficacy and safety of Direct Acting Antivirals on the elderly population is imperative.

Needle Exchange for Halting New Hep C Infections

Sep 13, 2017 3 Comments

Learn why there is an increasing number of new Hepatitis C infections, and what public health experts suggest to tackle this problem.

FDA Approves 1st Treatment of 8 Weeks Duration for All HCV Genotypes

Aug 7, 2017 5 Comments

Learn more about Mavyret, a new Hepatitis C drug that cured more than 92% of the 2,300 patients who were enrolled during clinical trials, in as little as 8 weeks.